first glp 1 approval Glucagon-like peptide-1 receptor: mechanisms and advances in therapy New GLP-1 Pill Foundayo (Orforglipron)

Although similar doses of glucoraphanin and glucoerucin were given in the sprouts and supplement, the total amounts of SFN and ERN metabolites in the plasma and urine were much lower in the supplement group compared to the sprout group.[23] The subjects got more sulforaphane out of raw sprouts than the supplement

It rises with inflammation

Conclusively, research on GLP-1R and its agonists marks a promising direction in metabolic disease therapy, extending their potential beyond glucose regulation and offering hope for more comprehensive approaches in addressing metabolic diseases

details live on the MIC-B12 product page

GIP is a hormone released from the small intestine after eating